Catecholamines in cardiac hypertrophy

American Journal of Cardiology

Volumn 83, Issue 12 A, 1999, Pages 70-74

  Scheuer, James ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C;

ALPHA ADRENERGIC STIMULATION; BETA ADRENERGIC STIMULATION; CELL GROWTH; CONFERENCE PAPER; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; ISOLATED HEART; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TRANSGENIC MOUSE;

EID: 0033577962     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00264-7     Document Type: Conference Paper

References (74)

1. Bristow M., Port J.D., Gilbert E., Sandoval A., Rasmussen R., Cates A.E., Feldman A.M. β-Adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation. 82:(suppl I):1990;I-12-I-25.
2. Homcy C.J., Vatner S.F., Vatner D.E. β-Adrenergic receptor regulation in the heart in pathophysiologic states abnormal adrenergic responsiveness in cardiac disease . Annu Rev Physiol. 53:1991;37-59.
3. Östman-Smith I. Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy. Clin Sci. 61:1981;265-272.
4. Morgan H.E., Baker K.M. Cardiac hypertrophy mechanical, neural, and endocrine dependence . Circulation. 83:1991;13-25.
5. Glennon P.E., Sugden P.H., Poole-Wilson P.A. Cellular mechanisms of cardiac hypertrophy. Br Heart J. 73:1995;496-499.
6. Laks M.M., Morady F., Swan H.J.C. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest. 64:1973;75-78.
7. King B.D., Sack D., Kichuk M.R., Hintze T.H. Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs. Hypertension. 9:1987;682-690.
8. Patel M.B., Stewart J.M., Loud A.V., Anversa P., Wang J., Fiegel L., Hintze T.H. Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine. Circulation. 84:1991;2091-2100.
9. Buttrick P., Malhotra A., Factor S., Geenen D., Scheuer J. Effects of chronic dobutamine administration on hearts of normal and hypertensive rats. Circulation. 63:1988;173-181.
10. Buttrick P., Perla C., Malhotra A., Geenen D., Lahorra M., Scheuer J. Effects of chronic dobutamine on cardiac mechanics and biochemistry after myocardial infarction in rats. Am J Physiol. 260:1991;H473-H479.
11. Zierhut W., Zimmer H.G. Significance of myocardial α- and β-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res. 65:1989;1417-1425.
12. Cooper G. IV. Basic determinants of myocardial hypertrophy a review of molecular mechanisms . Annu Rev Med. 48:1997;13-23.
13. Cooper G. IV, Kent R.L., Uboh C.E., Thompson E.W., Marino T.A. Hemodynamic versus adrenergic control of cat right ventricular hypertrophy. J Clin Invest. 75:1985;1403-1414.
14. Mann D.L., Kent R.L., Cooper G. IV. Load regulation of the properties of adult feline cardiocytes growth induction by cellular deformation . Circ Res. 64:1989;1079-1090.
15. Komuro I., Kaida T., Shibazaki Y., Kurabayashi M., Katoh Y., Hoh E., Takaku F., Yazaki Y. Stretching cardiac myocytes stimulates protooncogene expression. J Biol Chem. 265:1990;3595-3598.
16. Izumo S., Sadoshima J. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 59:1997;551-571.
17. Peterson M.B., Lesch M. Protein synthesis and amino acid transport in the isolated rabbit right ventricular papillary muscle. Effect of isometric tension development. Circ Res. 31:1972;317-327.
18. Xenophontos X.P., Gordon E.E., Morgan H.E. Effect of intraventricular pressure on protein synthesis in arrested rat hearts. Am J Physiol. 251:1986;C95-C98.
19. Von Harsdorf R., Lang R.E., Fullerton M., Woodcock E.A. Myocardial stretch stimulates phosphatidylinositol turnover. Circ Res. 65:1989;494-501.
20. Geenen D.L., Malhotra A., Buttrick P.M., Scheuer J. Ventricular pacing attenuates but does not reverse cardiac atrophy and an isomyosin shift in the rat heart. Am J Physiol. 267:1994;H2149-H2154.
21. Klein I., Hong C., Schreiber S.S. Isovolumic loading prevents atrophy of the heterotopically transplanted rat heart. Circ Res. 69:1991;1421-1425.
22. Simpson P., McGrath A., Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res. 51:1982;787-801.
23. 1 adrenergic response. J Clin Invest. 72:1983;732-738.
24. 1- adrenergic receptor interaction. Circ Res. 56:1985;884-894.
25. Simpson P.C., Long C.S., Waspe L.E., Henrich C.J., Ordahl C.P. Transcription of early developmental isogenes in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 21:(suppl V):1989;79-89.
26. 1C-adrenergic receptor from cardiac myocytes. Circ Res. 75:1994;796-802.
27. 1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. J Biol Chem. 271:1996;5839-5843.
28. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem. 1993;15374-15380.
29. Fuller S.J., Gaitanaki C.J., Sugden P.H. Effects of catecholamines on protein synthesis in cardiac myocytes and perfused hearts isolated from adult rats. Biochem J. 266:1990;727-736.
30. 1-Adrenergic stimulation is coupled to cardiac myocyte hypertrophy. Am J Physiol. 260:1991;H953-H956.
31. Schlüter K.D., Piper H.M. Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Physiol. 263:1992;H1739-H1746.
32. Decker R.S., Cook M.G., Behnke-Barclay M.M., Decker M.L., Lesch M., Samarel A.M. Catecholamines modulate protein turnover in cultured, quiescent rabbit cardiac myocytes. Am J Physiol. 265:1993;H329-H339.
33. Pinson A., Schlüter K.D., Zhou X.J., Schwartz P., Kessler-Icekson G., Piper H.M. Alpha- and beta-adrenergic stimulation of protein synthesis in cultured adult ventricular cardiomyocytes. J Mol Cell Cardiol. 25:1993;477-490.
34. Bogoyevitch M.A., Anderson M.B., Gillespie-Brown J., Clerk A., Glennon P.E., Fuller S.J., Sugden P.H. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J. 314:1996;115-121.
35. Schlüter K.D., Zhou X.J., Piper H.M. Induction of hypertrophic responsiveness to isoproterenol by TGF-β in adult rat cardiomyocytes. Am J Physiol. 269:1995;C1311-C1316.
36. Simpson P.C., Kariya K., Karns L.R., Long C.S., Karliner J.S. Adrenergic hormones and control of cardiac myocyte growth. Mol Cell Biochem. 104:1991;35-43.
37. Dubus I., Samuel J., Marotte F., Delcayre C., Rappaport L. β-Adrenergic agonists stimulate the synthesis of noncontractile but not contractile proteins in cultured myocytes isolated from adult rat heart. Circ Res. 66:1990;867-874.
38. Decker R.S., Cook M.G., Behnke-Barclay M., Decker M.L. Some growth factors stimulate cultured adult rabbit ventricular myocyte hypertrophy in the absence of mechanical loading. Circ Res. 77:1995;544-555.
39. i and creatine phosphate on α-adrenoceptor-mediated cardiac hypertrophy. J Mol Cell Cardiol. 30:1998;763-771.
40. McDermott P.J., Rothblum L.I., Smith S.D., Morgan H.E. Acclerated rates of ribosomal RNA synthesis during growth of contracting heart cells in culture. J Biol Chem. 264:1989;18220-18227.
41. 1-Adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. J Biol Chem. 263:1988;7352-7358.
42. Cooper G. IV, Mercer W.E., Hoober J.K., Gordon P.R., Kent R.L., Lauva I.K., Marino T.A. Load regulation of the properties of adult feline cardiocytes - the role of substrate adhesion. Circ Res. 58:1986;692-705.
43. Hefti M.A., Harder B.A., Eppenberger H.M., Schaub M.C. Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 9:1997;2873-2892.
44. Woodcock E.A., Schmauk White L.B., Smith A.I., McLeod J.K. Stimulation of phosphatidylinositol metabolism in the isolated, perfused rat heart. Circ Res. 61:1987;625-631.
45. 1A-adrenoceptor subtype. Circ Res. 82:1998;1078-1085.
46. Thorburn A., Thorburn J., Chen S., Powers S., Shubeita H.E., Feramisco J.R., Chien K.R. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem. 268:1993;2244-2249.
47. Page C., Doubell A.F. Mitogen-activated protein kinase (MAPK) in cardiac tissues. Mol Cell Biochem. 157:1996;49-57.
48. Fuller S.J., Davies E.L., Gillespie-Brown J., Sun H., Tonks N.K. Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes. Biochem J. 323:1997;313-319.
49. 1-adrenergic receptor and Ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem. 272:1997;14057-14061.
50. Gillespie-Brown J., Fuller S.J., Bogoyevitch M.A., Cowley S., Sugden P.H. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem. 270:1995;28092-28096.
51. Watson P.A. Mechanical activation of signaling pathways in the cardiovascular system. Trends Cardiol Med. 6:1996;73-79.
52. Kang P.M., Nakouzi A., Simpson T., Scheuer J., Buttrick P. Role of endogenous renin-angiotensin system in c-fos activation and PKC-εtranslocation in adult rat hearts. Am J Physiol. 270:1996;H2177-H2183.
53. 1-adrenergic stimulation. J Biol Chem. 269:1994;13490-13496.
54. Orita H., Fukasawa M., Hirooka S., Uchino H., Fukui K., Washio M. Modulation of cardiac myocyte rate and hypertrophy by cardiac fibroblasts isolated from neonatal rat ventricle. Jpn Circ J. 57:1993;912-920.
55. Long C.S., Hartogensis W.E., Simpson P.C. β-Adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. J Mol Cell Cardiol. 25:1993;915-925.
56. Long C.S. Autocrine and paracrine regulation of myocardial cell growth in vitro the TGFβ paradigm. Trends Cardiol Med. 6:1996;217-226.
57. D'Angelo D.D., Sakata Y., Lorenz J.N., Boivin G.P., Walsh R.A., Liggett S.B., Dorn G.W. II. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA. 57:(94):1997;8121-8126.
58. 1-adrenergic receptors. Circ Res. 81:1997;396-403.
59. 1-adrenergic induced gene expression in cultured cardiac myocytes. J Biol Chem. 271:1996;21134-21141.
60. Bristow M.R., Minobe W., Rasmussen R., Hershberger R.E., Hoffman B.B. Alpha-1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther. 247:1988;1039-1045.
61. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA. 91:1994;10109-10113.
62. 1B-adrenergic receptors. J Biol Chem. 272:1997;21253-21259.
63. 2-adrenergic receptor is associated with reduced phospholamban protein. J Clin Invest. 97:1996;1618-1623.
64. 2-adrenergic receptor. Science. 264:1994;582-586.
65. Koch W.J., Lefkowitz R.J., Milano C.A., Akhter S.A., Rockman H.A. Myocardial overexpression of adrenergic receptors and receptor kinases. Adv Pharmacol. 42:1998;502-506.
66. sα overexpression. Circ Res. 78:1996;517-524.
67. Schoen F.J., Berger B.M., Guerina N.G. Cardiac effects of noncardiac neoplasms. Cardiol Clin. 2:1984;657-670.
68. Agostini D., Scanu P., Babatasi G., Reznick Y., Darlas Y., Grollier G., Potier J.C., Mahoudeau J., Bouvard G. Pheochromocytoma with catecholamine-induced impairment of cardiac neuronal function. Am Heart J. 130:1995;1128-1130.
69. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 82:1990;1730-1736.
70. Testa M., Yeh M., Lee P., Fanelli R., Loperfido F., Berman J.W., LeJemtel T.H. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 28:1996;964-971.
71. Anker S.D., Chua T.P., Ponikowski P., Harrington D., Swan J.W., Kox W.J., Poole-Wilson P.A., Coats A.J.S. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 96:1997;526-534.
72. Schmieder R.E., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 275:1996;1507-1513.
73. Gottdiener J.S., Reda D.J., Massie B.M., Materson B.J., Williams D.W., Anderson R.J. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension. Circulation. 95:1997;2007-2014.
74. Devereux R.B. Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy? Circulation. 95:1997;1983-1985.